Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts.
Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts.
复制标题
DOI:
10.1186/1465-9921-12-57
复制
发表时间:
2011-04-27
影响因子:
5.8
通讯作者:
Boezen HM
中科院分区:
文献类型:
--
作者:
van Diemen CC;Postma DS;Siedlinski M;Blokstra A;Smit HA;Boezen HM
An imbalance in Matrix MetalloProteases (MMPs) and Tissue Inhibitors of MMPs (TIMPs) contributes to Chronic Obstructive Pulmonary Disease (COPD) development. Longitudinal studies investigating Single Nucleotide Polymorphisms (SNPs) in MMPs and TIMPs with respect to COPD development and lung function decline in the general population are lacking. We genotyped SNPs in MMP1 (G-1607GG), MMP2 (-1306 C/T), MMP9 (3 tagging SNPs), MMP12 (A-82G and Asn357Ser) and TIMP1 (Phe124Phe and Ile158Ile) in 1390 Caucasians with multiple FEV1 measurements from a prospective cohort study in the general population. FEV1 decline was analyzed using linear mixed effect models adjusted for confounders. Analyses of the X-chromosomal TIMP1 gene were stratified according to sex. All significant associations were repeated in an independent general population cohort (n = 1152). MMP2 -1306 TT genotype carriers had excess FEV1 decline (-4.0 ml/yr, p = 0.03) compared to wild type carriers. TIMP1 Ile158Ile predicted significant excess FEV1 decline in both males and females. TIMP1 Phe124Phe predicted significant excess FEV1 decline in males only, which was replicated (p = 0.10) in the second cohort. The MMP2 and TIMP1 Ile158Ile associations were not replicated. Although power was limited, we did not find associations with COPD development. We for the first time show that TIMP1 Phe124Phe contributes to excess FEV1 decline in two independent prospective cohorts, albeit not quite reaching conventional statistical significance in the replication cohort. SNPs in MMPs evidently do not contribute to FEV1 decline in the general population.
登录
查看更多内容
DOI:
10.1006/bbrc.2001.5936
发表时间:
2001-11-23
影响因子:
3.1
作者:
Minematsu, N;Nakamura, H;Yamaguchi, K
通讯作者:
Yamaguchi, K
DOI:
10.1056/nejmoa0904006
发表时间:
2009-12-31
期刊:
The New England journal of medicine
影响因子:
--
作者:
Hunninghake GM;Cho MH;Tesfaigzi Y;Soto-Quiros ME;Avila L;Lasky-Su J;Stidley C;Melén E;Söderhäll C;Hallberg J;Kull I;Kere J;Svartengren M;Pershagen G;Wickman M;Lange C;Demeo DL;Hersh CP;Klanderman BJ;Raby BA;Sparrow D;Shapiro SD;Silverman EK;Litonjua AA;Weiss ST;Celedón JC
通讯作者:
Celedón JC
DOI:
10.1164/rccm.200506-953oc
发表时间:
2005-12-01
影响因子:
24.7
作者:
Ito, I;Nagai, S;Mishima, M
通讯作者:
Mishima, M
影响因子:
3.5
作者:
Joos, L;He, JQ;Sandford, AJ
通讯作者:
Sandford, AJ
影响因子:
9.6
作者:
GLINDMEYER, HW;JONES, RN;WEILL, H
通讯作者:
WEILL, H